MARASCHI, ALESSANDRA
MARASCHI, ALESSANDRA
Universita' degli Studi di MILANO
Hemochromatosis in Italy in the last 30 years : role of genetic and acquired factors
2010 A.L. Fracanzani, A. Piperno, L. Valenti, M. Fraquelli, S. Coletti, A. Maraschi, D. Consonni, E. Coviello, D. Conte, S. Fargion
Hemochromatosis in Italy in the last 30 years : role of genetic and acquired factors
2009 A.L. Fracanzani, A. Piperno, L. Valenti, M. Fraquelli, S. Coletti, A. Maraschi, D. Consonni, E. Coviello, D. Conte, S. Fargion
Carotid artery intima-media thickness in nonalcoholic fatty liver disease
2008 A.L. Fracanzani, L. Burdick, S.L. Raselli, P.S. Pedotti, L. Grigore, G. Santorelli, L.V.C. Valenti, A. Maraschi, A.L. Catapano, S.R. Fargion
Progression of carotic atherosclerotic damage is related to alt values in patients with non alcoholic fatty liver disease
2008 E.A. Pulixi, L. Burdick, L. Valenti, C. Bertelli, E. Fatta, A. Maraschi, M. Sampietro, S. Fargion, A.L. Fracanzani
Long-term survival and risk of hepatocellular carcinoma occurrence in Italian patients with hereditary hemochromatosis
2008 A.L. Fracanzani, L. Valenti, A. Maraschi, M. Fraquelli, S. Coletti, A. Piperno, D. Conte, S. Fargion
Long-Term survival and risk of hepatocellular carcinoma occurrence in Italian patients with hereditary hemochromatosis
2008 A.L. Fracanzani, L. Valenti, A. Maraschi, M. Fraquelli, S. Coletti, A. Piperno, D. Conte, S. Fargion
Contrast-enhanced ultrasonography (CEUS) and spiral computed tomography (CT) in the assessement of efficacy of percutaneous ablation treatments of hepatocellular carcinoma in cirrhosis
2008 A. L Fracanzani, A. Maraschi, L. Burdick, C. Bertelli, E. Fatta, N. Bonelli, D. Meregaglia, S. Fargion
Progression of carotic atherosclerotic damage is related to ALT values
2008 A.L. Fracanzani, L.V.C. Valenti, L. Burdick, C. Bertelli, E. Fatta, A. Maraschi, E.A. Pulixi, S.R. Fargion
Revisitation of a cohort of 482 italian patients with hereditary hemochromatosis : changes in the last three decades
2007 A.L. Fracanzani, L. Valenti, A. Maraschi, M. Fraquelli, S. Coletti, A. Piperno, D. Conte, S. Fargion
Revisitation of a cohort of 482 italian patients with hereditary hemochromatosis : changes in the last three decades
2007 A.L. Fracanzani, L. Valenti, A. Maraschi, M. Fraquelli, S. Coletti, A. Piperno, D. Conte, S. Fargion
Triple antiviral therapy in HCV positive patients who failed prior combination therapy
2006 S.R. Fargion, M. Borzio, A. Maraschi, A. Cargnel
Are the determinants of steatosis Associated with chronic hepatitis C( CHC) different from those of non alcoholic fatty liver disease ( NAFLD? )
2006 E.A. Pulixi, A.L. Fracanzani, A. Maraschi, C. Bertelli, S.R. Fargion
Insulin related early andothelial dysfuction in patients with non alcoholic fatty liver disease (NAFLD)
2006 L. Burdick, G. Santorelli, L. Valenti, A. Maraschi, A. Orsatti, C. Bertelli, A.L. Fracanzani, S.R. Fargion
Risk of early atherosclerosis evaluated by carotid artery intima-media thickness in patients with non-alcoholic fatty liver disease : a case control study
2006 A.L. Fracanzani, L. Burdick, S. Raselli, P. Pedotti, L. Grigore, G. Santorelli, L. Valenti, A. Maraschi, A. Catapano, S.R. Fargion
Differential patterns of contrast-enhancement ultrasonography with SonoVue in small focal lesions arisng in cirrhosis
2006 C. Bertelli, A.L. Fracanzani, L. Burdick, A. Sangiovanni, N. Bonelli, M. Borio, A. Maraschi, G.P. Benedetti, S.R. Fargion
Sustained virological response (SVR) to peginterferon alfa-2a (40 KD) (PEGASYS) plus ribavirin (RBV) and amantadine (AMA) Vs induction therapy with interferon alfa-2a (roferon-A) plus RBV and AMA in IFN/RBV non responders (NR) with chronic hepatitis C
2006 A. Maraschi, M. Borzio, A. Cargnel, S.R. Fargion